New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
09:12 EDTBBY, CSX, UNH, AMGN, ILMN, SRPT, NUS, BLK, APO, CEC, SCHW, YHOO, JCP, C, HPQ, AMRNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Charles Schwab (SCHW), up 3%... BlackRock (BLK), up 1.5%. ALSO HIGHER: CEC Entertainment (CEC), up 13% after acquired by Apollo (APO) affiliate for $54 per share... HP (HPQ), up 2% after upgraded at BofA Merrill Lynch... Sarepta Therapeutics (SRPT), up 16% after announcing that data from a study of eteplirsen demonstrates continued stability in walking test... Illumina (ILMN), up 4.8% after in agreement with Amgen (AMGN) to develop oncology companion diagnostic test. DOWN AFTER EARNINGS: Citigroup (C), down 2.6%... CSX (CSX), down 6%.... UnitedHealth (UNH), down 0.5%. ALSO LOWER: Best Buy (BBY), down 30% after reporting domestic Holiday same-store sales fell 0.9%... Yahoo (YHOO), down 2% after COO Henrique de Castro to leave company effective January 16 after reportedly clashing with CEO Mayer... J.C. Penney (JCP), down 3.9% after announcing plans to close 33 underperforming stores and cut 2K jobs... after reporting earnings and revenue that just slightly missed estimates... Nu Skin (NUS), down 16.3% after responding to People's Daily article that called it a "pyramid scheme"... Amarin (AMRN), down 9.6% after the FDA delayed its ANCHOR SPA appeal, shares downgraded at MKM Partners.
News For BBY;HPQ;C;JCP;YHOO;SCHW;CEC;APO;BLK;NUS;SRPT;ILMN;AMGN;UNH;CSX;AMRN From The Last 14 Days
Check below for free stories on BBY;HPQ;C;JCP;YHOO;SCHW;CEC;APO;BLK;NUS;SRPT;ILMN;AMGN;UNH;CSX;AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
August 19, 2014
12:14 EDTCCitigroup considers selling Japan retail-banking unit, WSJ reports
Subscribe for More Information
11:32 EDTILMNLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
11:05 EDTHPQImperva seen as takeover candidate under new CEO
Subscribe for More Information
10:42 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
08:59 EDTHPQHewlett-Packard volatility increases into Q3 and outlook
Subscribe for More Information
08:42 EDTHPQImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.
05:48 EDTYHOOStocks with implied volatility movement; AEO YHOO
Subscribe for More Information
05:11 EDTAMGNGamida Cell announces investment, option agreement with Novartis
Subscribe for More Information
August 18, 2014
17:25 EDTAMGNAmgen announces AMG 416 study met its primary and all secondary endpoints
Amgen announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism, SHPT, in patients with chronic kidney disease,CKD, receiving hemodialysis, met its primary and all secondary endpoints. "The results from this second Phase 3 study help to confirm that AMG 416 could become an important new treatment option for dialysis patients with secondary hyperparathyroidism," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "Despite the variety of options available for the treatment of this disease, an unmet need remains for an intravenous therapy that can be administered along with hemodialysis. We look forward to sharing results of a head-to-head study evaluating AMG 416 compared to cinacalcet next year."
16:00 EDTCOptions Update; August 18, 2014
Subscribe for More Information
13:12 EDTHPQMicrosoft getting ready to launch Chromebook challengers, 9to5Google says
Subscribe for More Information
11:57 EDTJCPStocks with call strike movement; JCP GPRO
J.C. Penney (JCP) November 11 call option implied volatility decreased 4% to 43, GoPro (GPRO) January 48 call option implied volatility decreased 8% to 45 according to IVolatility.
10:01 EDTHPQOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Hold at Deutsche Bank... CNOOC (CEO) upgraded to Neutral from Underperform at Credit Suisse... Dollar General (DG) upgraded to Buy from Neutral at Sterne Agee... Equity Residential (EQR) upgraded to Hold from Underperform at Jefferies... HMS Holdings (HMSY) upgraded to Overweight from Equal Weight at First Analysis... HP (HPQ) upgraded to Buy from Neutral at Monness Crespi... Halcon Resources (HK) upgraded to Buy from Hold at MLV & Co.... KapStone (KS) upgraded to Buy from Hold at Deutsche Bank... Sportsman's Warehouse (SPWH) upgraded at RW Baird... Westlake Chemical (WLK) upgraded to Neutral from Reduce at SunTrust... WisdomTree (WETF) upgraded to Neutral from Sell at Citigroup... Zimmer (ZMH) upgraded to Outperform from Market Perform at William Blair.
09:54 EDTNUSNu Skin mentioned cautiously by Bronte Capital
Reference Link
09:35 EDTCActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
09:01 EDTCECWestwood Holdings Group appoints Tiffany Kice as CFO
Subscribe for More Information
07:41 EDTHPQHP upgraded to Buy from Neutral at Monness Crespi
07:39 EDTHPQHP remains a top pick ahead of Q3 results at Deutsche Bank
Subscribe for More Information
06:47 EDTCU.S. banks consider Ireland fitting spot for EU divisions, FT says
Subscribe for More Information
06:23 EDTYHOOYahoo acquires Israel-based ad startup ClarityRay, terms not disclosed
Israel-based ad startup ClarityRay announced on its website that it has been acquired by Yahoo. Terms of the deal have not been disclosed. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use